...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Discussion Forum: Resverlogix Corp.
Message Title
Rating
Author / Date
5
Nov 12, 2019 02:49PM
7
Nov 12, 2019 11:49AM

Nov 12, 2019 09:33AM
3
Nov 12, 2019 09:26AM
1
Nov 12, 2019 09:25AM
6
bfw
Nov 12, 2019 08:38AM